Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen Ginkgo Bioworks Holdings stake
total: 652
Viking Global Investors DNA trades
- Total transactions:
- 7
- New positions:
- 1
- Added:
- 2
- Reduced:
- 4
- Held since:
- 2021 Q3
- Held for:
- 19 quarters
- Latest activity:
- 2024 Q3
According to 2026 Q1 report, Ole Andreas Halvorsen holds 3,577,128 Ginkgo Bioworks Holdings (DNA) shares with a market value of roughly $21.93M accounting for 0.06% of the overall portfolio. To date, the estimated cost basis is nearly $8.65 for "buy" trades and estimated average "sell" price is $4.94. Viking Global Investors first purchased DNA in 2021 Q3, initially acquiring about 339.06M shares. Since the initial investment in Ginkgo Bioworks Holdings (DNA), Viking Global Investors has made 6 more transactions.
When did Ole Andreas Halvorsen buy Ginkgo Bioworks Holdings (DNA)?
Ole Andreas Halvorsen first invested in Ginkgo Bioworks Holdings (DNA) in 2021 Q3 at the reported quarter-end price of $11.59 per share.
What's the cost basis of Viking Global Investors's DNA stake?
The estimated cost basis for Ginkgo Bioworks Holdings (DNA) stake is around $8.65 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $8.65
- Weighted AVG sell price:
- $4.94
Ole Andreas Halvorsen's historical trades in Ginkgo Bioworks Holdings
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q3
|
0.11%
|
3,577,128
|
$8.15
|
$29,153,593
|
-97.50% (-139,507,998)
|
-4.37%
|
|
2023 Q1
|
0.89%
|
143,085,126
|
$1.33
|
$190,303,218
|
+126.81% (+80,000,000)
|
+0.5%
|
|
2022 Q4
|
0.53%
|
63,085,126
|
$1.69
|
$106,613,863
|
-38.05% (-38,749,000)
|
-0.3%
|
|
2022 Q3
|
1.47%
|
101,834,126
|
$3.12
|
$317,722,000
|
+275.99% (+74,750,000)
|
+1.08%
|
|
2022 Q2
|
0.29%
|
27,084,126
|
$2.38
|
$64,460,000
|
-46.95% (-23,971,018)
|
-0.23%
|
|
2022 Q1
|
0.83%
|
51,055,144
|
$4.03
|
$205,752,000
|
-84.94% (-288,000,000)
|
-3.34%
|
|
2021 Q3
|
10.78%
|
339,055,144
|
$11.59
|
$3,929,649,000
|
new
|
+10.78%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.